Search results for “Type 2 diabetes” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 8,157 patents, we discovered top 455 key players by total patent application. Merck Sharp & Dohme Corp., AstraZeneca Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 14.70% of the total patent filing.
New Jersey, United States
Patent: 443
Jiangsu Sheng, China
Patent: 427
Switzerland
Patent: 329
Indiana, United States
Patent: 325
New Jersey, United States
Patent: 304
Hessen, Germany
Patent: 290
California, United States
Patent: 228
Basel-Stadt, Switzerland
Patent: 224
Rheinland-Pfalz, Germany
Patent: 202
California, United States
Patent: 197
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 125 patents, we discovered top 19 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Cellix Bio Pvt Ltd., Intarcia Therapeutics, Inc. are active in this area.
STARTUP
France
Patent: 26
STARTUP
Telangana, India
Patent: 17
California, United States
Patent: 15
STARTUP
Bretagne, France
Patent: 13
STARTUP
Massachusetts, United States
Patent: 13
STARTUP
California, United States
Patent: 7
STARTUP
Pennsylvania, United States
Patent: 7
STARTUP
Kayothera, Inc.
New Jersey, United States
Patent: 6
STARTUP
Massachusetts, United States
Patent: 4
STARTUP
Changing Health Ltd.
United Kingdom
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,695 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Amgen, Inc., Eli Lilly & Co., AstraZeneca Pharmaceutical Co., Ltd. take 9.68% of patent filing during this period.
California, United States
Patent: 64
Indiana, United States
Patent: 58
Jiangsu Sheng, China
Patent: 42
Tokyo-to, Japan
Patent: 37
Antwerpen, Belgium
Patent: 29
Zhejiang Sheng, China
Patent: 26
Rheinland-Pfalz, Germany
Patent: 26
New York, United States
Patent: 19
California, United States
Patent: 17
Massachusetts, United States
Patent: 17
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,695 patents in last 5 years, we discover 313 new entrants. Gmax Biopharm LLC, Sprint Bioscience AB, I2o Therapeutics, Inc. are the most active new entrants in this area.
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,421 patents, we discovered top 272 universities and scientific research institutions by total patent application. The Salk Institute for Biological Studies, Kharkiv National Medical University, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 9.08% of the total patent filing.
California, United States
Patent: 37
Ukraine
Patent: 35
Shanghai Shi, China
Patent: 22
Illinois, United States
Patent: 20
Jiangsu Sheng, China
Patent: 18
Israel
Patent: 14
Jiangsu Sheng, China
Patent: 14
Massachusetts, United States
Patent: 14
United Kingdom
Patent: 13
New Hampshire, United States
Patent: 13
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: